Cooperative effect of GNB3 825C>T and GPIIIa PI(A) polymorphisms in enhanced platelet aggregation

Thrombosis Research

Volumn 109, Issue 5-6, 2003, Pages 279-286

  Frey, Ulrich H ^a   Aral, Nese ^a   Müller, Norbert ^a   Siffert, Winfried ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

G protein; Platelet; Polymorphism; Signal transduction; Thrombosis

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; FIBRINOGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLYCOPROTEIN IIIA; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN SUBUNIT;

ADULT; ALLELE; ARTICLE; CELL DENSITY; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFECT; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MALE; NORMAL HUMAN; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; RESTRICTION MAPPING; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; STUDENT T TEST; THROMBOCYTE AGGREGATION; THROMBOSIS; TURBIDIMETRY;

EID: 0038683381     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(03)00253-6     Document Type: Article

References (36)

1. Fuster V., Badimon L., Badimon J.J., Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N. Engl. J. Med. 326(4):1992;242-250.
2. Fitzgerald D.J., Roy L., Catella F., FitzGerald G.A. Platelet activation in unstable coronary disease. N. Engl. J. Med. 315(16):1986;983-989.
3. Savage B., Saldivar E., Ruggeri Z.M. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 84(2):1996;289-297.
4. Offermanns S., Laugwitz K.L., Spicher K., Schultz G. G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets. Proc. Natl. Acad. Sci. U. S. A. 91(2):1994;504-508.
5. Shenker A., Goldsmith P., Unson C.G., Spiegel A.M. The G protein coupled to the thromboxane A2 receptor in human platelets is a member of the novel Gq family. J. Biol. Chem. 266(14):1991;9309-9313.
6. Paul B.Z., Jin J., Kunapuli S.P. Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors. J. Biol. Chem. 274(41):1999;29108-29114.
7. Simonds W.F., Goldsmith P.K., Codina J., Unson C.G., Spiegel A.M. Gi2 mediates alpha 2-adrenergic inhibition of adenylyl cyclase in platelet membranes: in situ identification with G alpha C-terminal antibodies. Proc. Natl. Acad. Sci. U. S. A. 86(20):1989;7809-7813.
8. Morrison A.C., Doris P.A., Folsom A.R., Nieto F.J., Boerwinkle E. G-protein beta3 subunit and alpha-adducin polymorphisms and risk of subclinical and clinical stroke. Stroke. 32(4):2001;822-829.
9. Brass L.F., Manning D.R., Cichowski K., Abrams C.S. Signaling through G proteins in platelets: to the integrins and beyond. Thromb. Haemost. 78(1):1997;581-589.
10. Terres W., Weber K., Kupper W., Bleifeld W. Age, cardiovascular risk factors and coronary heart disease as determinants of platelet function in men. A multivariate approach. Thromb. Res. 62(6):1991;649-661.
11. Kjeldsen S.E., Rostrup M., Gjesdal K., Eide I. The epinephrine-blood platelet connection with special reference to essential hypertension. Am. Heart J. 122(1 Pt 2):1991;330-336.
12. Renaud S.C., Beswick A.D., Fehily A.M., Sharp D.S., Elwood P.C. Alcohol and platelet aggregation: the Caerphilly Prospective Heart Disease Study. Am. J. Clin. Nutr. 55(5):1992;1012-1017.
13. Richardson M., Robishaw J.D. The alpha2A-adrenergic receptor discriminates between Gi heterotrimers of different betagamma subunit composition in Sf9 insect cell membranes. J. Biol. Chem. 274(19):1999;13525-13533.
14. Rosskopf D., Manthey I., Siffert W. Identification and ethnic distribution of major haplotypes in the gene GNB3 encoding the G-protein beta3 subunit. Pharmacogenetics. 12(3):2002;209-220.
15. Siffert W., Rosskopf D., Siffert G., Busch S., Moritz A., Erbel R.et al. Association of a human G-protein beta3 subunit variant with hypertension. Nat. Genet. 18(1):1998;45-48.
16. Virchow S., Ansorge N., Rosskopf D., Rübben H., Siffert W. The G protein beta3 subunit splice variant Gbeta3-s causes enhanced chemotaxis of human neutrophils in response to interleukin-8. Naunyn-Schmiedeberg's Arch. Pharmacol. 360(1):1999;27-32.
17. Lindemann M., Virchow S., Ramann F., Barsegian V., Kreuzfelder E., Siffert W.et al. The G protein beta3 subunit 825T allele is a genetic marker for enhanced T cell response. FEBS Lett. 495(1-2):2001;82-86.
18. Feng D., Lindpaintner K., Larson M.G., Rao V.S., O'Donnell C.J., Lipinska I.et al. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. Arterioscler. Thromb. Vasc. Biol. 19(4):1999;1142-1147.
19. Weiss E.J., Bray P.F., Tayback M., Schulman S.P., Kickler T.S., Becker L.C.et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N. Engl. J. Med. 334(17):1996;1090-1094.
20. Feng D., Lindpaintner K., Larson M.G., O'Donnell C.J., Lipinska I., Sutherland P.A.et al. Platelet glycoprotein IIIa Pl(a) polymorphism, fibrinogen, and platelet aggregability: the Framingham Heart Study. Circulation. 104(2):2001;140-144.
21. Charo I.F., Feinman R.D., Detwiler T.C. Interrelations of platelet aggregation and secretion. J. Clin. Invest. 60(4):1977;866-873.
22. Virchow S., Ansorge N., Rübben H., Siffert G., Siffert W. Enhanced fMLP-stimulated chemotaxis in human neutrophils from individuals carrying the G protein beta3 subunit 825 T-allele. FEBS Lett. 436(2):1998;155-158.
23. Baumgart D., Naber C., Haude M., Oldenburg O., Erbel R., Heusch G.et al. G protein beta3 subunit 825T allele and enhanced coronary vasoconstriction on alpha(2)-adrenoceptor activation. Circ. Res. 85(10):1999;965-969.
24. Naber C.K., Hüsing J., Wolfhard U., Erbel R., Siffert W. Interaction of the ACE D allele and the GNB3 825T allele in myocardial infarction. Hypertension. 36(6):2000;986-989.
25. Yamada Y., Izawa H., Ichihara S., Takatsu F., Ishihara H., Hirayama H.et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N. Engl. J. Med. 347(24):2002;1916-1923.
26. von Beckerath N., Kastrati A., Koch W., Bottiger C., Mehilli J., Seyfarth M.et al. G protein beta3 subunit polymorphism and risk of thrombosis and restenosis following coronary stent placement. Atherosclerosis. 149(1):2000;151-155.
27. Brand E., Herrmann S.M., Nicaud V., Ruidavets J.B., Evans A., Arveiler D.et al. The 825C/T polymorphism of the G-protein subunit beta3 is not related to hypertension. Hypertension. 33(5):1999;1175-1178.
28. Hengstenberg C., Schunkert H., Mayer B., Döring A., Löwel H., Hense H.W.et al. Association between a polymorphism in the G protein beta3 subunit gene (GNB3) with arterial hypertension but not with myocardial infarction. Cardiovasc. Res. 49(4):2001;820-827.
29. Naber C., Hermann B.L., Vietzke D., Altmann C., Haude M., Mann K.et al. Enhanced epinephrine-induced platelet aggregation in individuals carrying the G protein beta3 subunit 825T allele. FEBS Lett. 484(3):2000;199-201.
30. Meirhaeghe A., Bauters C., Helbecque N., Hamon M., McFadden E., Lablanche J.M.et al. The human G-protein beta3 subunit C825T polymorphism is associated with coronary artery vasoconstriction. Eur. Heart J. 22(10):2001;845-848.
31. Wenzel R.R., Siffert W., Bruck H., Philipp T., Schäfers R.F. Enhanced vasoconstriction to endothelin-1, angiotensin II and noradrenaline in carriers of the GNB3 825T allele in the skin microcirculation. Pharmacogenetics. 12(6):2002;489-495.
32. Swart S.S., Maguire M., Wood J.K., Barnett D.B. Alpha 2-adrenoceptor coupling to adenylate cyclase in adrenaline insensitive human platelets. Eur. J. Pharmacol. 116(1-2):1985;113-119.
33. Ingerman-Wojenski C.M., Silver M.J. A quick method for screening platelet dysfunctions using the whole blood lumi-aggregometer. Thromb. Haemost. 51(2):1984;154-156.
34. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 324(7329):2002;71-86.
35. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial. Lancet. 356(9247):2000;2037-2044.
36. Simoons M.L. Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial. Lancet. 357(9272):2001;1915-1924.